Global Veterinary Anti-infectives Market, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
Global Veterinary Anti-infectives Market Overview
"The Veterinary Anti-infectives Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031."
The purpose of veterinary anti-infectives is to prevent and do treatment for deadly animal diseases. Veterinary anti-infectives are much helpful to prevent transmitting foodborne and zoonotic diseases to humans from animals. These diseases are transmitted to humans naturally from animals due to consumption of contaminated water and food, direct contact with infected animals, or exposure to pathogens during preparation of food. These diseases are serious global public health problems. Thus, veterinary anti-infectives are very important to save humans and animals from various deadly diseases.
One among some of the key factors driving growth of the global market is increasing awareness about better animal health. Increasing burden of zoonotic and foodborne diseases is projected positively affect growth of the global market. According to a survey conducted in 2017 by the Centers for Disease Control and Prevention (CDC), approximately 3,000 die, 128,000 are hospitalized, and 48 million get infected each year owing to foodborne diseases in the US.
Thus, there is an increasing need for curbing these outbreaks, which, in turn, is increasing the demand for veterinary anti-infectives. Increasing pressure on livestock owners to maintain veterinary health standards for meeting demand for fresh meat, dairy products, animal vaccines, and dietary nutrition is projected to further drive growth of the global veterinary anti-infectives market over the forecast period. Moreover, demand for veterinary anti-infectives has been increasing due to increasing pet adoption, the prevalence of bacterial infections, and increasing concerns regarding pet health.
Staphylococcal infection, actinomycosis and nocardiosis, leptospirosis, and bacterial ear infection are among some of the infections that affect animals. In addition, pets are also susceptible to different bacterial diseases such as brucellosis, plague, and Lyme disease. According to a report by the CDC in 2018, cats are more easily infected by plague than dogs and can pass on to humans as well. Increasing technological advancements and new product inventions are projected to create growth opportunities for key players in the global veterinary anti-infectives market over the forecast period.
Global Veterinary Anti-infectives Market Segment Analysis:
By Animal Type: Among the animal type segments, the livestock segment is projected to contribute the highest revenue share to the global veterinary anti-infectives market. This trend is expected to continue over the forecast period. This growth of the segment can be attributed to increasing meat consumption and daily growing need for it.
By Product Type: The antibacterial segment among the product type segments is projected to continue its dominance in terms of revenue share over the forecast period. This can be attributed to increasing prevalence of bacterial infections in companion animals and livestock. Moreover, various activities by WHO to address health threats at the human-animal-ecosystem interface are attributed to the growth of the segment.
Global Veterinary Anti-infectives Market Regional Analysis:
North America accounts for highest revenue share currently in the global veterinary anti-infectives market, which is expected to continue over the forecast period. This can be attributed to the increasing adoption of pet animals in the region and the prevalence of deadly diseases such as zoonotic and foodborne diseases. Also, increasing meat consumption in countries in the region is attributed to the growth of the regional market.
Global Veterinary Anti-infectives Market Segmentation:
By Animal Type:
- Sheep & Goats
- Companion animal
By Product Type:
- Others (Quinoles, sulfonamides, polymyxins)
By Route of Administration:
By Distribution Channel
- Veterinary Clinics
- Retail Pharmacies
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Bayer AG
- Cipla Limited
- Dechra Pharmaceuticals PLC
- Eli Lilly and Company (Elanco Animal Health)
- Heska Corp (Diamond Animal Health)
- Merck & Co., Inc. (Merck Animal Health)
- Neogen Corporation
- Phibro Animal Health Corporation
- Sanofi (Merial Animal Health)
- Vetoquinol S.A.
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!